Latest Capital Management News

EZZ Life Science Holdings Limited has announced a fully franked ordinary dividend of AUD 0.02 per share for the six months ending December 2024, signaling steady returns for shareholders.

Computershare Limited reaffirmed its FY25 guidance at the Macquarie Australia Conference, projecting a 15% increase in management EPS supported by strong revenue growth and disciplined capital management.

Vicinity Centres reports a robust third quarter for FY25, driven by strong retailer demand and shopper confidence, highlighted by the successful launch of The Market Pavilion at Chadstone.

Vicinity Centres reports a robust third quarter for FY25, buoyed by record visitation at Chadstone’s new Market Pavilion and strong retail sales growth. The company now expects full-year earnings at the top end of guidance, underpinned by resilient portfolio metrics and strategic asset management.

Spheria Emerging Companies Limited has updated its dividend distribution approach, opting to use cash dividends to buy shares on-market due to the share price falling below its post-tax NTA per share on the ex-dividend date.

Healius Limited has announced a special fully franked dividend of AUD 0.413 per ordinary share, signaling confidence in its financial position despite the ongoing suspension of its Dividend Reinvestment Plan.

Healius Limited has announced a fully franked special dividend of 41.3 cents per share totaling approximately $300 million, alongside a new $300 million three-year syndicated bank facility replacing its previous $680 million arrangement.

Pact Group Holdings has received conditional approval from the ASX for its voluntary delisting, pending shareholder endorsement at an upcoming extraordinary general meeting scheduled for 12 June 2025.

US Masters Residential Property Group has amended its loan agreement with Global Atlantic, significantly lowering its Tangible Net Worth covenant to align with a strategic sales-driven reduction in debt.

AdAlta Limited has announced a pro rata renounceable rights offer to raise approximately $1.29 million, aiming to fund its strategic pivot towards licensing CAR-T cell therapies through its subsidiary AdCella. The offer includes new shares and options, underpinned by key insiders and an underwriting agreement.

Anagenics Ltd has reported a significant earnings turnaround in 3Q25 following a strategic business restructure, alongside securing a multi-year royalty agreement worth $4.4 million with York Street Brands.

Boom Logistics reports robust 3Q FY25 results with revenue and profit gains led by renewables projects, while pausing its share buy-back after meeting targets.